Latest Biotech News

Raina Biosciences has introduced GEMORNA, a deep generative AI platform designed to engineer mRNA sequences with enhanced translational efficiency and stability for therapeutic applications....

Data presented at the European Society of Cardiology meeting demonstrated that Novartis' cholesterol-lowering medication Leqvio rapidly improved lipid profiles in high-risk patients when added to...

Alnylam Pharmaceuticals reported that their RNA interference drug zilebesiran did not achieve a statistically significant blood pressure reduction in a key Phase 2 trial involving patients with...

The FDA has approved a new subcutaneous formulation of Leqembi, Eisai and Biogen’s Alzheimer's treatment, enhancing administration options for patients suffering from early-stage disease. This...

A US district court ruled in favor of NeoGenomics, invalidating two of Natera's patents related to minimal residual disease (MRD) detection assays. This ruling allows NeoGenomics to market its...

Johns Hopkins University researchers developed MIGHT, a novel AI method optimizing sensitivity and specificity in early cancer screening. Unlike typical accuracy-focused algorithms, MIGHT balances...

Buck Institute researchers discovered in an Alzheimer's disease mouse model that colonic immune cells, particularly CXCR4+ IgA-secreting B cells, migrate to the brain, potentially contributing to...

A pivotal study published in JAMA reports that a single dose of a respiratory syncytial virus (RSV) vaccine substantially reduces severe illness and hospitalization among older adults across two...

Organ transplantation continues to benefit from technological and procedural breakthroughs. Normothermic Regional Perfusion (NRP) is emerging as a transformative technique in liver...

Artificial intelligence (AI) and machine learning are reshaping oncology research and patient care. Johns Hopkins University introduced MIGHT, a novel AI method optimizing early cancer detection...

Recent data highlights significant progress in novel therapeutic agents. Sanofi secured FDA approval for rilzabrutinib, its BTK inhibitor, advancing its immunology portfolio targeting rare...

Cutting-edge research is advancing protein and RNA-based therapeutics. Raina Biosciences unveiled GEMORNA, a generative AI platform that designs mRNA sequences with enhanced stability and...

Recent investigations offer new insights into neurodegeneration and brain health. Adaptive deep brain stimulation (aDBS) demonstrates improved outcomes for Parkinson’s disease motor symptoms. The...

Groundbreaking studies clarify mechanisms of cancer progression and therapeutic resistance. Research reveals branched-chain amino acids fuel tumor growth, while a long non-coding RNA network...

The biotech sector experiences robust capital influx and partnerships bolstering innovation. Patient Square Capital closed over $3 billion for its second fund, emphasizing healthcare investment....

Cutting-edge cellular therapies are redefining transplant and cancer treatment modalities. UCLA researchers engineered AlloCAR70-NKT, an off-the-shelf immunotherapy targeting metastatic kidney...

Recent regulatory and market activities underscore pivotal shifts in the biotech industry. The FDA approved a subcutaneous formulation of Eisai and Biogen’s Alzheimer’s drug Leqembi, intensifying...

The FDA granted approval to Sanofi's BTK inhibitor, rilzabrutinib, marking a critical expansion in Sanofi's immunology portfolio. Acquired through the $3.7 billion purchase of Principia Biopharma,...

Zephyr AI, a developer of AI-driven platforms for personalized cancer medicine, has expanded its real-world oncology data resources through the acquisition of Aster Insights. This move grants...

Researchers at UCLA have engineered AlloCAR70-NKT cells, an off-the-shelf immunotherapy harnessing engineered natural killer T cells to target CD70-expressing metastatic renal cell carcinoma. This...